|Articles|December 10, 2015

An Increasingly Global Approach: January 2016 Therapeutic Innovation & Regulatory Science

Author(s)DIA

DIA Publications Editor-in-Chief Dr. Stephen P. Spielberg previews the upcoming issue of Therapeutic Innovation & Regulatory Science, including articles on clinical trial outcomes, contributions on data quality and central monitoring from TransCelerate BioPharma, and a series of contributions emphasizing the increasingly global nature of medical product development and regulation.

Click here to read the article.

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

An Increasingly Global Approach: January 2016 Therapeutic Innovation & Regulatory Science

Related Content

EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval

The New Healthy Aging Imperative and What It Means for Pharma

Reading Between the Lines: Closing the T1D Misdiagnosis Gap

Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer

Beyond the Strip: Las Vegas Has a New Kind of Venture in Mind

Trending on PharmExec

EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval

Reading Between the Lines: Closing the T1D Misdiagnosis Gap

The Rise of Direct-to-Patient Models in Pharma: Opportunities and Risks in Bypassing Traditional Distribution Channels

The New Healthy Aging Imperative and What It Means for Pharma

Novartis Announces $105 Million Collaborative Agreement with Antares Therapeutics